Skip to main content
News > Blog > The COVID19 Pandemic Response Proves Value of Open Science

The COVID19 Pandemic Response Proves Value of Open Science

Subject: COVID19 and Open Science Discoveries and Developments

 

COVID19, the novel “Coronavirus Disease 2019”, has proven the value proposition “open science” and Open Therapeutics’ free scientific collaborative platform, Therapoid.

Lives are being saved due to the implementation of open science.

Multiple outlets around the world are covering how open science is rapidly making discoveries around COVID19. (1)(2)(3)

Even the U.S. Administration is now supporting and promoting open science. (4)

The private sector simply can’t do this.  

The private sector does not constitute a global think-tank because their cultures and organizations are built around closed science.  Also, they don’t have the labor force.  

Similar to Linux and the open source movement, the private sector companies do not have the labor force, infrastructure, or intellectual property structures to quickly muster resources to collaborate.

Open Therapeutics’ https://Therapoid.net, which is in beta, is positioned to help scientists around the world to freely and openly collaborate on solving the COVID19 crisis.

Therapoid will do this by providing an end-to-end scientific ecosystem that has free tools, services, access to up to $4T worth of unused intellectual properties (IP), and soon will reward scientific collaborations with AnthroTokens cryptocurrency.

One can think of Open Therapeutics as a “Github® for scientists” that rewards collaboration with a blockchain-based cryptocurrency.

The age of open science is upon us and Open Therapeutics is at the edge of delivering life saving opportunities.

 

(1) https://www.channelnewsasia.com/news/commentary/covid-19-coronavirus-china-open-science-journal-data-research-12468852

(2) https://www.linkedin.com/feed/update/urn:li:activity:6636402241873997824/

(3) https://www.benzinga.com/pressreleases/20/02/n15423852/roadmap-for-open-science-to-reduce-barriers-and-speed-up-discovery

(4) President Trump’s Science Advisor and Government Science Leaders from Around the World call on Publishers to make all COVID-19-Related Research Publically Available. https://twitter.com/whostp/status/1238501576123265025?s=21

We Believe

Open Therapeutics crowdsources orphan and dormant therapeutic intellectual properties (IP) to scientists around the world. The goal is advancing research that ordinarily has not generated a public value or been recognized. This approach particularly helps underserved scientists to collaborate with their more financially capable colleagues.

How open science helps researchers succeed:

Open access, open data, open source, and other open scholarship practices are growing in popularity and necessity. However, widespread adoption of these practices has not yet been achieved. One reason is that researchers are uncertain about how sharing their work will affect their careers.

The review of the literature demonstrates that open science is associated with increases in citations, media attention, potential collaborators, job opportunities, and funding opportunities. These findings are evidence that open science practices bring significant benefits to researchers relative to more traditional closed practices.

Secured By miniOrange